Study Design Highlights Study type: In vitro (Caco-2 cell model) and preclinical animal model Compound: Astragaloside II (key bioactive from Astragalus membranaceus) Outcomes: Cellular activity and growth, L-arginine uptake, transport pathway activity, protein signaling, intestinal structure markers Key Findings (What the Study Showed) Astragaloside II associated with increased cellular activity and growth in intestinal cell models, suggesting support for normal cellular function Increased uptake of L-arginine and supported activity of transport pathways involved in nutrient absorption Influenced signaling pathways involved in protein metabolism and cellular activity, indicating support for normal cellular processes Animal models: Improvements in markers related to intestinal structure and overall physiological condition Why This Study Matters This study identifies Astragaloside II as a key bioactive compound within Astragalus membranaceus that contributes to AstraGin's overall function specifically supporting amino acid uptake and cellular activity at the intestinal level
EMA Decision P/0336/2024 Retatrutide Paediatric Investigation Plan (confirming no marketing authorisation)
Our team listens, adjusts, and plans around your needs
213 In contrast, another study showed that cytokines secreted by NKT cells in the hepatic microenvironment may contribute to macrophage phenotype reprogramming, facilitating liver repair following IRI
Quick Answer: GLP-1 receptor agonists are not officially linked to generalized sensitive skin, though injection site reactions occur in 2-10% of patients and rare allergic skin reactions have been reported
